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INTRODUCTION
The recent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic is
currently straining the global health system. Little is still known about this novel Coronavirus
(CoV), despite the efforts of the scientific community worldwide. So far, analogies with the previous
infamous outbreaks of Severe Acute Respiratory Syndrome (SARS) in 2003 and Middle East
Respiratory Syndrome (MERS) in 2012, caused by other CoV strains, have offered some insight,
but we are still sailing in uncharted waters.
Although all CoV infections are initiated by the transmembrane spike (S) glycoprotein, a
homotrimeric class I viral fusion protein, the binding site on the host cell surface differs among CoV
strains (Figure 1A). MERS-CoV weakly binds to non-acetylated sialoside attachment receptors
on epithelial cells of the respiratory tract, promoting clustering and facilitating its binding to
its receptor dipeptidyl peptidase-4 (DPP4) (1). The novel SARS-CoV-2, despite having evolved
independently, shares with the previous SARS-CoV the cell receptor for Angiotensin Converting
Enzyme 2 (ACE2) (2). However, a novel study by the Italian Institute of Technology (3) suggests
that there is an in-silico evidence that, in addition to ACE2, certain sialic acids on the cell surface
may act as additional receptors for binding sites of the S protein of SARS-CoV-2, thus playing
a role in the pathogenicity and epidemiology of the associated disease, as it has already been
demonstrated for MERS-CoV. Sialic acids could therefore be used by SARS-CoV-2 as attachment
receptors on the epithelium of the respiratory tract, promoting SARS-CoV-2 clustering, as already
known for MERS-CoV (1). As a result, virus-ACE2 binding could be facilitated. Furthermore,
a recent research by Vandelli and colleagues explored the structural properties of SARS-CoV-2
strains through computational approaches, and found that the ACE2 binding site is conserved
among strains, whereas the potential SARS-CoV-2-sialic acid binding domain is highly variable, as
reported in MERS-CoV. This variability could result in different binding affinities of SARS-CoV-2
strains for cellular sialic acids, possibly explaining the broad range of host-immune responses in
the human population (4).
THE HUMAN SIALOME
The Sialome Evolution
The human sialome, i.e., the broad variety of sialic acid compounds in the human body, has been
hypothesized to be the result of genomic changes occurred under the selective impulse of an alleged
pandemic event, roughly 3 million years ago, provoking the so-called sialoquake.
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Varki has well-described the paramount role of sialic acids
in pandemic events. Observing that humans only synthesize
N-Acetyl-Neuraminic Acid (NeuAc), whilst in humans’ closest
evolutionary relatives both NeuAc and N-Glycolylneuraminic
acid (NeuGc) can be found, Varki postulated that some
unknown pathogen caused the evolutionary selection of a
specific variant of the enzyme CMP-N-acetylneuraminic acid
hydroxylase (CMAH), responsible for a key reaction in the
synthesis of NeuGc. This unknown pathogen, having a high
affinity for NeuGc binding, caused a pandemic event that
exerted an evolutionary pressure, leading to the deletion
of one exone in the CMAH gene, that made the enzyme
incapable of synthesizing NeuGc, while the synthesis of
NeuAc remained untouched. Although differing only by one
oxygen atom, the altered proportions of NeuAc and NeuGc
(loss of the latter and relative increase of the former),
allegedly altered human susceptibility to pathogens, protecting
them from NeuGc-binding pathogens, while exposing them
to NeuAc-binding ones (5). This difference in neuraminic
acid synthesis between humans and other mammals still
has relevant consequences. Although MERS-CoV receptor,
DDP4, does not differ between humans and dromedaries or
horses, MERS-CoV’s natural hosts, the latter appear to be
resistant to experimental MERS infection, suggesting that other
factors are involved in host susceptibility. Noting that MERS-
CoV has a binding site of high selectivity for NeuAc that
excludes NeuGc, and that NeuAc is less represented in horses
lower airways, it could be speculated that the differences in
sialoglycomes among species affect host susceptibility and tissue
tropism (1).
The Antiviral Protective Role of the Sialome
Sialic acid viral recognition has been long known to be
a virulence factor for various pathogens (6). However, the
sialome exerts also a protective effect against viral infections
(Figure 1B). As a host defense mechanism, sialylated O-linked
glycans covering mucins on mucosal cell surfaces provide a large
layer of sialylated residues that acts as a barrier, preventing
pathogens from entering the cell by offering a decoy alternative
binding site.
In vivo studies have demonstrated that knockout Muc1−/−
mice (i.e., genetically modified to lack mucin 1) challenged
with H1N1 Influenza A virus reach maximal viral titers earlier
and with greater inflammatory response using equivalent viral
challenge titers, compared to their wild-type counterparts (7).
As further proof of the protective role of sialylated compounds,
it is worth mentioning how concentration of oligosaccharides
(HMOs), glycosylated components of human breast milk, in
HIV-positive women correlates with reduced HIV transmission
to the nursling through breastfeeding. Moreover, it is well-
known how HMOs interfere with viral glycoprotein recognition
of Norovirus and Rotavirus, playing a pivotal anti-viral role,
which, in addition to their positive effect on neurodevelopmental
outcomes, has justified their supplementation in infant formulas
(8). However, HMOs’ potential role in preventing, limiting or
modulating SARS-CoV-2 infection has not been explored, yet.
Sialome Age and Sex-Related
Modifications
Like most of the human body components, the sialome
undergoes aging-dependent deleterious processes as well.
Sialylation is a modification through which a sialic acid unit is
added at the end of an oligosaccharide chain in a glycoprotein.
Among sialylated serum proteins, IgG-Fc terminal glycan
sialylation has been extensively studied for its importance in
inflammatory diseases, either autoimmune or infectious, due
to the modulation of pro- and anti-inflammatory cascades by
aglycosylated and glycosylated IgGs, respectively. Recent studies
have identified an age-related accumulation of aglycosylated
IgGs, which is linked to a pro-inflammatory status, typical of
the elderly. Moreover, elderly patients exhibit a lower sialic
acid content in saliva compared to children, confirming that
sialylation processes decrease all over the body with aging.
Similarly, sialome seems to be affected by the body’s hormonal
asset, in that estrogens upregulate antibody sialylation, determing
an anti-inflammatory effect, whilst a decrease in estrogen levels,
as seen in menopause, leads to lower sialylation activity. In line
with these findings, pregnancy seems to be a “highly sialylated
status,” which may reflect the well-known reduced incidence
of inflammatory or autoimmune disease flares during this
period of time. Interestingly, trans-placental passage of maternal
glycosylated IgGs results in the anti-inflammatory IgG profile of
new-borns, with glycosylated IgG levels that decrease over the
years, until they reach adult levels (9). Applying these findings to
the current pandemic situation, it could be interesting to assess
whether a low-sialylated environment in men and elderly could
play a role in SARS-CoV-2 infection both by favoring infection
initiation, due to the low-grade sialylation of the defensive
respiratory mucus, and by enhancing the inflammatory state
caused by the subsequent cytokine storm, partly explaining the
higher prevalence and severity of COVID-19 in male and older
patients and the diminished aggressiveness in pregnant women
and new-borns (10).
DISCUSSION
At the present level of knowledge, it cannot be confirmed nor
excluded that COVID-19 clinical manifestations differ according
to individual differences in sialic acid expression on cell surfaces.
However, what is already known about the human sialome
and CoV strains allows us to postulate that the epidemiologic
characteristics of COVID-19 (greater severity in male and older
individuals) may be partially explained by the sex and age-related
differences of sialome among humans.
Despite multiple data generated using anti-viral repurposed
drugs, to date neither a vaccine nor any effective specific
treatment are available. Even anti-inflammatory drugs have
not obtained regulatory approvals to be used to fight the
cytokine storm causing the Acute Respiratory Distress Syndrome
(ARDS), the most severe expression of Acute Lung Injury
(ALI). Prevention as well has been limited by the extreme
contagiousness of SARS-CoV-2 and, to this day, the most
effective measure has been general lockdown. A deeper
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FIGURE 1 | (A) Sialic acid recognition as an infection facilitator for Coronavirus strains. (1) MERS-CoV binds to non-acetylated sialoside receptors on the epithelial
cells of the respiratory tract, promoting clustering and facilitating its binding to its receptor DPP4. (2) SARS-CoV binds to ACE2 receptor. (3) SARS-CoV-2 binds to
ACE2 receptor, but a surface region in Spike protein is very similar to MERS-CoV spike sialic acid-binding region, suggesting a possible role of sialic acid recognition in
infection initiation. (B) Sialic acid recognition as a host defense mechanism for Coronavirus strains. (1) MERS-CoV can bind to sialylated O-linked glycans covering
(Continued)
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FIGURE 1 | mucins on mucosal cell surfaces, thus being trapped in the mucous layer and consequently eliminated through ciliary movement. (2) SARS-CoV passes
through the mucous layer without being stopped by decoy alternative binding sites. (3) SARS-CoV-2 shares with MERS-CoV the sialic acid binding region of Spike
protein, and could therefore bind to sialylated O-linked glycans similarly to MERS-CoV, thus possibly being eliminated through ciliary movement.
comprehension of the role of human sialome in this pandemic
could contribute to the development of preventive strategies
targeted at the most vulnerable subjects, maybe even considering
upregulating sialylation through the supplementation of
exogenous synthetic sialylated compounds, as it has already
been done in other contexts and for other purposes in infant
formulas. Indeed, sialic acids could be provided to patients
within a combined therapy to reduce inflammation and
viral load, that ultimately result in the COVID-19 associated
respiratory distress syndrome, the most severe COVID-19
expression, able to determine more than 50% of COVID-19
associated deaths.
In conclusion, we think that, altogether, data provided here
should help to consider sialic acids as an important game-changer
in the SARS-CoV-2 infection, since there are still several virus-
cell interaction aspects that need to be discovered. Due to SARS-
CoV-2′s low selective-pressure, we aren’t currently facing a quake
like that of 3 million years ago; however, every step made
now toward a better comprehension of human susceptibility to
pathogens would nonetheless have a paramount role in facing
emerging global health threats.
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